TTR1 nano-agonist Abs (Teikyo Heisei University/SymBio)

N/A

Report date: 2025/01/26 15:57:00

Base Information

Drug NameTTR1 nano-agonist Abs (Teikyo Heisei University/SymBio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10A agonists
TargetsTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeikyo Heisei University
China Registration ClassN/A

Develop Information

Active CompaniesTeikyo Heisei UniversitySymBio Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A